Evidence map›Paper›PMID 30046154›Full record

ArticleScientific reports2018

Structural determinants of the catalytic mechanism of Plasmodium CCT, a key enzyme of malaria lipid biosynthesis.

Ewelina Guca, Gergely N Nagy, Fanni Hajdú, Lívia Marton, Richard Izrael, François Hoh, Yinshan Yang, Henri Vial, Beata G Vértessy, Jean-François Guichou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Evaluation of Antimalarial Activity of Ethanolic Extract ofJournal of evidence-based integrative medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Ewelina GucaDynamique des Interactions Membranaires Normales et Pathologiques, UMR 5235, CNRS, Université de Montpellier, Montpellier, France.
Gergely N NagyDepartment of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Budapest, Hungary.
Fanni HajdúDepartment of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Budapest, Hungary.
Lívia MartonInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
Richard IzraelDepartment of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Budapest, Hungary.
François HohCNRS UMR5048, Centre de Biochimie Structurale, Université de Montpellier, Montpellier, France.
Yinshan YangCNRS UMR5048, Centre de Biochimie Structurale, Université de Montpellier, Montpellier, France.
Henri VialDynamique des Interactions Membranaires Normales et Pathologiques, UMR 5235, CNRS, Université de Montpellier, Montpellier, France.
Beata G VértessyDepartment of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Budapest, Hungary.
Jean-François GuichouCNRS UMR5048, Centre de Biochimie Structurale, Université de Montpellier, Montpellier, France.
Rachel CerdanDynamique des Interactions Membranaires Normales et Pathologiques, UMR 5235, CNRS, Université de Montpellier, Montpellier, France. rachel.cerdan@umontpellier.fr.
Institute of Molecular Life Sciences · HUUniversité de Montpellier · FRCentre National de la Recherche Scientifique · FRHungarian Academy of Sciences · HUHUN-REN Research Centre for Natural Sciences · HUInstitute for Research in Biomedicine · ESLaboratory of Pathogens and Host Immunity · FR

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-09-BLAN-0397Magyar Tudományos Akadémia (Hungarian Academy of Sciences) CRP/HUN14-01
6 · The paper itself

Abstract

The development of the malaria parasite, Plasmodium falciparum, in the human erythrocyte, relies on phospholipid metabolism to fulfil the massive need for membrane biogenesis. Phosphatidylcholine (PC) is the most abundant phospholipid in Plasmodium membranes. PC biosynthesis is mainly ensured by the de novo Kennedy pathway that is considered as an antimalarial drug target. The CTP:phosphocholine cytidylyltransferase (CCT) catalyses the rate-limiting step of the Kennedy pathway. Here we report a series of structural snapshots of the PfCCT catalytic domain in its free, substrate- and product-complexed states that demonstrate the conformational changes during the catalytic mechanism. Structural data show the ligand-dependent conformational variations of a flexible lysine. Combined kinetic and ligand-binding analyses confirm the catalytic roles of this lysine and of two threonine residues of the helix αE. Finally, we assessed the variations in active site residues between Plasmodium and mammalian CCT which could be exploited for future antimalarial drug design.

Indexed as

Amino Acid SequenceAnimalsAntimalarialsCatalysisCatalytic DomainCholine-Phosphate CytidylyltransferaseHumansKineticsLigandsLipidsLipogenesisMalaria, FalciparumPlasmodium falciparumProtein BindingSubstrate SpecificityAntimalarialsCholine-Phosphate CytidylyltransferaseLigandsLipids

Identifiers

PMID30046154
PMCPMC6060094
OpenAlexW2883232809

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.